Abstract:Intracerebral hemorrhage (ICH) will be accompanied by the overload of iron and reactive oxygen species (ROS) following hematoma clearance. Although deferoxamine (DFO) has been widely utilized as a clinical first-line siderophore to remove the iron overload, the ROS-inducing damage still greatly limits the therapeutic effect of DFO. To address this issue, we designed and fabricated a series of dual-functional macromolecular nanoscavengers featuring high-density DFO units and catechol moieties. Note that the former units could effectively remove the iron overload, while the latter ones could efficiently deplete the ROS. The resulting nanoscavengers efficiently down-regulate the iron and ROS levels as well as significantly reduce the cell death in both iron-overloaded RAW 264.7 cells and the ICH mice model. This work suggests a novel clue for the ICH-ameliorated iron-depleting interventional therapeutic regimen.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c00491?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c00491</a>.Details of material preparation; hemocompatibility of nanoscavengers in vitro; synthesis scheme of poly(DFO-PEGm)n; ESI-MS and HPLC spectra of Cat–DFO, UV–vis spectra of 3,4-dihydroxyhydrocinnamic acid, DFO, Cat-DFO, P0, P1, P2, and P3; FT-IR spectra of Cat-DFO, P0, and P3; 1H NMR spectra of P1, P2, and P3; average size and zeta potential value of P3 in different media obtained by DLS; UV-Vis spectra of P3 solution with different concentrations before and after binding with Fe2+ for 12 h; UV-Vis spectra of the bottom filtrate of DFO and P3 after binding with Fe2+ for 12 h; RBC deformability of the precipitate of RBC suspension incubated with P3 and H2O for 1 h at different shear stress; PT of PPP after incubation with DFO, P1, P2, and P3 with different concentrations; cell viability of RAW 264.7 cells after incubating with DFO, P1, P2, and P3 of different concentrations for 48 h using the alamarBlue assay; flow cytometry result of RAW 264.7 cells stimulated with different concentrations of Fe2+, FAC (Fe3+) for 0.5 h using DCFH-DA as the fluorescent probe; bodyweight of normal mice, ICH mice treated with saline, DFO, and P3 nanoscavenger; and instrument for ICH mouse model construction (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c00491/suppl_file/am1c00491_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Platelet‐Membrane‐Coated Polydopamine Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Repairing Damaged Vessels in Intracerebral Hemorrhage

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

An Ultrasmall Cu/Cu<sub>2</sub>O Nanoparticle-Based Diselenide-Bridged Nanoplatform Mediating Reactive Oxygen Species Scavenging and Neuronal Membrane Enhancement for Targeted Therapy of Ischemic Stroke

Metal ion-responsive nanocarrier derived from phosphonated calix[4]arenes for delivering dauricine specifically to sites of brain injury in a mouse model of intracerebral hemorrhage

Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury

Neutrophil-like pH-responsive pro-efferocytic nanoparticles improve neurological recovery by promoting erythrophagocytosis after intracerebral hemorrhage

Platelet Membrane‐Coated Curcumin‐PLGA Nanoparticles Promote Astrocyte‐Neuron Transdifferentiation for Intracerebral Hemorrhage Treatment

Diselenide-Bridged Mesoporous Silica-Based Nanoplatform with a Triple ROS-Scavenging Effect for Intracerebral Hemorrhage Treatment

A Novel Targeted Nanoparticle for Traumatic Brain Injury Treatment: Combined Effect of ROS Depletion and Calcium Overload Inhibition

Thrombus inhibition and neuroprotection for ischemic stroke treatment through platelet regulation and ROS scavenging

A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic Stroke

A neurovascular dual-targeting platelet-like bioinspired nanoplatform for ischemic stroke treatment

Efficient Iron and ROS Nanoscavengers for Brain Protection after Intracerebral Hemorrhage

Polydopamine-Cloaked Nanoarchitectonics of Prussian Blue Nanoparticles Promote Functional Recovery in Neonatal and Adult Ischemic Stroke Models

Platelet Membrane Biomimetic Magnetic Nanocarriers for Targeted Delivery and in Situ Generation of Nitric Oxide in Early Ischemic Stroke.

Platelet‐Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury

Neutrophil membrane-based biomimetic metal-polyphenol self-assembled nanozyme for the targeting treatment of early brain injury following subarachnoid hemorrhage

Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke

ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy

Precisely co-delivery of protein and ROS scavenger with platesomes for enhanced endothelial barrier preservation against myocardial ischemia reperfusion injury

Macrophage-Targeted multifunctional nanoparticles for detection and treatment of intraplaque hemorrhage